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ABSTRACT  
Advanced bioanalysis, including accurate quantitation, has driven the need to understand biology and 
medicine at the molecular level. Bioconjugated silica nanoparticles have the potential to address this emerging 
challenge. Particularly intriguing diagnostic and therapeutic applications in cancer and infectious disease 
as well as uses in gene and drug delivery, have also been found for silica nanoparticles. In this review, we 
describe the synthesis, bioconjugation, and applications of silica nanoparticles in different bioanalysis formats, 
such as selective tagging, barcoding, and separation of a wide range of biomedically important targets. 
Overall, we envisage that further development of these nanoparticles will provide a variety of advanced tools 
for molecular biology, genomics, proteomics and medicine.  
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Introduction
Recently, we have seen the discovery of an increasing 
number of molecular mechanisms underlying disease 
processes. Consequently, clinical diagnosis has come 
to depend heavily on detection and monitoring of 
individual chemical interactions of smaller and less 
abundant targets, such as individual cells, mRNA, 
DNA, proteins, and peptides. Because these targets 
exist on a nanoscale, probes of equivalent dimensions 
have been developed, leading to the integration of 
nanotechnology and biology. This progress, in turn, 
has led to major advances in medical diagnostics, 
targeted therapeutics, molecular biology, and cell 
biology [1 3]. Thus, the adaptation of nanomaterials 
for biology and medicine has changed the bio-
analytical measurement landscape and yielded 
several promising schemes for widespread use [4
7]. In addition, the demand for gene profiling and 
high-throughput drug and disease screening without 
complex instrumentation or processing steps has 
driven the development of novel substrates for fast, 
simple, ultrasensitive, and multiplexed bioanalysis. 
Among the different nanomaterials developed 
for bioanalysis, nanoparticles (NPs) usually form 
the core of bio-nanomaterials. They can be used as a 
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convenient surface for molecular assembly and may 
be composed of inorganic or polymeric materials 
[8]. In the past decade, a variety of nanomaterials 
such as quantum dots (QDs) [9, 10], metal NPs [11, 
12], lanthanide NPs [13, 14], and silica NPs [15] 
have each shown their unique properties and been 
adapted to different applications in the bioanalysis 
field. Among these, QDs are the most intriguing 
class of fluorescent probes for cellular imaging and 
in vivo cell tracking because of their small size (1 10 
nm in diameter), high brightness (20× brighter than 
most organic fl uorophores), good photostability, and 
multiplexing capability. However, several properties 
limit the widespread use of QDs. The core of QDs 
is composed of toxic heavy metals (e.g., cadmium); 
therefore, cytotoxicity is a definite concern for in 
vivo applications. QDs are not soluble in water, and 
must be surface modified with a polymer to allow 
for use in biological applications. In addition, single 
colloidal quantum dots emit intermittently (the so-
called “blinking” behavior) which is a limiting factor 
for single particle tracking within cells. 
Recently, different fluorescent silica NPs with 
similar composition and functionalization (known 
as FloDots and Cornell dots) have emerged as 
a particularly fascinating fluorescent probe and 
attracted widespread interest in biology and 
medicine [15 19]. The variety of chemical and 
physical modifi cations possible with silica increases 
its versatility, and its biocompatibility makes it a 
relatively benign material. Finally, the silica NP 
probe is highly hydrophilic and easy to centrifuge 
for separation, surface modification, and labeling 
procedures. The silica NPs exhibit enhanced and 
controllable mechanical and chemical stability and 
their porosity can also be easily tailored in terms of 
pore size and organization. Thus, they are superior to 
polystyrene latex NP probes, which have signifi cant 
drawbacks. For instance, the hydrophobic property 
of polystyrene results in easy agglomeration of NPs 
in aqueous media, and its density (1.05 g/cm3) leads 
to difficulties in separation from solution after the 
surface modifi cation and labeling processes [20].
Highly luminescent si l ica NPs have been 
developed for the selective tagging of a wide range 
of biomedically important targets, such as cancer 
cells, bacteria, and individual biomolecules [16, 
19]. Compared to organic fluorophores, which are 
the most commonly used bio-labeling reagents, 
luminescent silica NPs demonstrate the advantages of 
multiplexing capabilities and ease of functionalization, 
as well as greater sensitivity and photostability. The 
advanced optical features of fluorescent silica NP 
probes are critical for ultrasensitive bio-imaging 
and detection as well as for real-time tracking and 
monitoring of complex biological events at the cellular 
level, which cannot be accomplished using regular 
fl uorescent dyes. 
In addition, analysis of complex biological samples 
typically requires sample pre-treatment. Multi-step 
procedures, such as solid-phase extraction (SPE), are 
typically used for sample preparation but they do not 
remove analytes selectively [21]. In contrast, silica 
NPs with superparamagnetic properties have been 
developed as ideal media for the manipulation of 
trace amounts of bioanalytes from complex biological 
matrices in applications ranging from detection, 
separation to targeted delivery for hyperthermia 
treatment [15, 22].
 Silica NPs are also promising candidates for 
improved drug delivery systems. Drug molecules 
have been loaded into silica NPs, and surface 
modifi cation of the NPs with biorecognition entities 
can allow specifi c cells or receptors in the body to be 
located [23]. Upon target recognition, NPs can release 
their drug payload at a rate that can be precisely 
controlled by tailoring the internal structure of the 
particles for a desired diffusion/release profi le.
It is also possible to make multifunctional 
silica NPs with the aim of developing nanoscale 
composites with innovative optical, chemical, and 
magnetic properties, all combined in one single 
nanostructure [24, 25]. For instance, magnetic-
fluorescent silica NPs based on iron oxide NPs 
combined with fluorophores can be simultaneously 
manipulated with an external magnetic field and 
characterized in situ with fl uorescence microscopy or 
confocal scanning microscopy. Such multifunctional 
magnetic/fluorescent NPs are potentially useful for 
imaging cells, tissues, and other organs in multiple 
modes, as well as for the delivery of therapeutic 
agents to specifi c targets. 
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This article provides an overview of recent 
progress in silica NP research, with special emphasis 
on applications in the fi elds of bio-labeling, imaging, 
separation, disease diagnostics and therapeutics, 
and other related technologies. Challenges and 
perspectives of silica NP probes are also discussed. 
Although there are other nanomaterials under 
development, we are unable to cover the entire 
landscape and therefore only provide the reader with 
the work being conducted in the silica NP fi eld.
1. Silica NP synthesis and bionconjugation
Spherical silica NPs are generally made by one of 
two synthetic routes: reverse microemulsion or the 
Stöber method.  The reverse micelle or water-in-
oil (w/o) microemulsion system is composed of a 
homogeneous mixture of water, oil, and surfactant 
molecules [26 28]. The single-phase microemulsion 
system is both isotropic and thermodynamically 
stable. Water nanodroplets form in the bulk oil 
phase, which then act as a confined medium (of 
nanoreactors) for discrete particle formation. Polar 
and water-soluble dye molecules can be readily 
encapsulated into silica NPs by this method [29 33] 
because of the electrostatic attraction of dye 
molecules to the negatively charged silica matrix. To 
synthesize organic dye-doped NPs, various trapping 
methods have been applied, such as introducing a 
hydrophobic silica precursor [34] or using water-
soluble dextran-conjugated dyes under acidic 
conditions [35]. An advantage of the microemulsion 
system lies in its typical output of monodisperse and 
highly uniform NPs [36]. However, fl uorophores are 
physically attached to the silica matrix and may leach 
out of the particles over time. Furthermore, the use of 
surfactants necessitates extensive washing to remove 
the surfactant molecules before any biological 
application in order to avoid disruption or lysis of 
biomembranes by the surfactant molecules.
As an alternative, the Stöber method [37] can be 
applied for synthesizing fairly monodisperse silica 
particles with diameters ranging from 30 nm to 2 μm. 
In the Stöber process, silica particles are formed by the 
hydrolysis and condensation of siloxane precursors 
(e.g., tetraethylorthosilicate (TEOS)) in the presence 
of ethanol and ammonia. This method has been 
modified to incorporate a variety of organic dye 
molecules [38 41] within the silica NPs by covalent 
attachment. The procedure involves two steps. First, 
the dye is chemically bound to an amine-containing 
silane agent (such as 3-aminopropyltriethoxysilane, 
APTS), and, second, APTS and TEOS are allowed to 
hydrolyze and co-condense to form dye-doped NPs. 
A wide variety of organic dye molecules (Fig. 1) 
can be incorporated into silica NPs using the Stöber 
method. The same doping procedure has also 
been used to incorporate other materials into the 
silica matrix, such as magnetic NPs of Fe3O4 and 
Fe2O3 or luminescent quantum dots [29, 42, 43]. 
Magnetic NPs or quantum dots are used as seeds 
for hydrolysis and condensation of TEOS, resulting 
in silica-coated NPs.  In addition, mesoporous silica 
NPs [44] have also been prepared by a surfactant 
(e.g., cetyltrimethylammonium bromide (CTAB), 
templated co-condensation method using TEOS 
and organosiloxane precursors [45], or they can be 
formed by reacting diglyceroxysilane in ethanol and 
Figure 1   Fluorescent silica NP architecture may be expanded to 
incorporate a wide range of dye molecules including (left to right): 
fluorescein isothiocyanate, Oregon green, rhodamine, rhodamine 
6G, tetramethylrhodamine, Texas red, 6-carboxyl-X-rhodamine, and 
cyanine Cy5. A representative TEM image shows the NP size is~40 nm
in diameter
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methanol-free conditions in pure water or in buffer 
solutions [46]. 
Once NPs have been formed, an additional layer 
of linker molecules with various reactive functional 
groups (e.g., amine, thiol, carboxyl or methacrylate) is 
often attached. This is typically achieved by applying 
an additional silica coating (post-coating) that 
contains the desired functional group(s). In addition 
to providing the reaction sites for bioconjugation, the 
functional groups also change the colloidal stability 
of NPs in solution. For example, inert negatively 
charged organosilane compounds containing 
phosphonate groups can be introduced into NPs 
during post-coating [47]. This step increases the 
repulsive forces between the particles in solution and 
thus improves long-term NP stability. In addition, 
polyethylene glycol (PEG, a neutral polymer) can also 
be introduced to the NP surface in order to reduce 
nonspecific binding by inhibiting the adsorption of 
undesired charged biomolecules [48]. 
After NPs have been modified with different 
functional groups, they can act as a scaffold for the 
grafting of biological moieties, such as biocompatibles 
(e.g., dextran, antibodies, DNA or peptides), by 
means of standard covalent bioconjugation schemes 
[49] (Fig. 2), such as carbodiimide chemistry, 
disulfi de-coupling chemistry and succinimidyl ester 
hydrolysis chemistry. 
In addition to covalent binding to the NP surface, 
bio-recognition entities can also be physically 
adsorbed onto the NP surface using electrostatic 
interactions between NPs and charged adapter 
molecules [50, 51] or between NPs and proteins 
modifi ed to incorporate charged domains. However, 
covalent binding of biomolecules to NPs is preferred, 
not only to avoid desorption from the NP surface, 
but also to control the number and orientation of the 
immobilized biorecognition entities. 
2. NP characterization
Characterization of NPs typically includes measuring 
the particle size, surface charge, surface functionalitiy, 
and optical and magnetic properties. Transmission 
electron microscopy (TEM) and scanning electron 
microscopy (SEM) are commonly used to evaluate the 
NP size in the vacuum state [40, 41]; light scattering 
techniques are applied to measure NP size in 
aqueous media while providing NP size distribution 
and relative dispersion [52].
The zeta potential of a particle indicates the 
overall charge that the particle acquires in a particular 
medium. The resulting repulsive force can be used 
to predict the colloidal stability of the NP product. If 
all the particles in suspension possess a large positive 
or negative zeta potential, they will repel each other, 
thus avoiding NP agglomeration. Conversely, low 
zeta potential values result in the tendency of NPs 
to flocculate, or coagulate loosely. 
Therefore, surface modification 
is usually performed in order 
to increase the repulsive forces 
between the particles in solution 
and hence improve the long-term 
stability of NPs [53]. Furthermore, 
the effect  of  varying the pH, 
concentration of an additive, or the 
ionic strength of the medium on 
the zeta potential and rheological 
properties can give information 
which helps in formulating the NP 
product to give maximum stability.
T h e  a p p l i c a t i o n  o f  d y e -
doped silica NPs for bioimaging 
and labeling depends on their 
Figure 2   Representative bioconjugation schemes for the attachment of biomolecules onto 
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optical properties, and there are several advantages 
of fluorescent NPs over commonly used organic 
dyes. First, better sensitivity can be achieved by 
incorporating a large number of dye molecules in a 
single NP system. For example,  tetramethylrhodamine 
(TMR) dye-doped silica NPs (60 nm in diameter) can 
each emit an extremely strong fluorescence signal 
(up to 104 times that of a TMR fluorophore) [54], 
achieving high signal amplifi cation for ultrasensitive 
target detection and for monitoring rare events 
that are otherwise undetectable with conventional 
fluorophore labeling strategies. Secondly, because 
of the protective encapsulation of fluorophores by 
the host silica material, increased photostability is 
generally attained in NPs. This feature makes NPs 
particularly useful as fl uorescent markers in complex 
biological environments, where it is often desirable to 
observe markers for extended periods of time against 
the background of intrinsic cellular emissions [31]. 
Moreover, the potential of preparing NPs with any 
existing single or multiple fl uorophore(s) gives NPs a 
unique versatility for various applications, including 
multiplexed bioanlaysis [55]. Finally, whereas organic 
fluorophores require customized chemistry for 
conjugation of biomolecules to each fluorophore, 
a universal approach can be used for conjugating 
biomolecules to all silica NPs.
3. Applications of silica NPs
The advanced features of silica NP probes give them 
a substantial advantage for use in the detection of 
single molecules, bioimaging and extraction of cells 
and cellular components, as well as disease targeting. 
The scope of their applications ranges from biology 
to medicine. 
3.1   Cancer cell imaging
For effective cellular labeling techniques, biomarkers 
need to have excellent specifi city toward biomolecules 
of interest and also have optically stable signal 
transducers. Immunofluorescent labeling of both 
cancer cell surface marker and tissue sections by dye-
doped silica NPs has demonstrated high specificity 
and high intensity, thus making direct observation 
for instant diagnosis of pathological samples during 
surgical procedures a possibility [56]. Different 
strategies have been explored for using NP probes to 
target cancer cells. 
First, affinity and specificity associated with the 
antibody-antigen recognition have been widely 
explored in developing immunoassays. Primary or 
secondary antibodies are covalently immobilized 
onto the NP surface in order to selectively and 
effi ciently bind various cancer cells [31, 57, 58]. In one 
demonstration, a mouse anti-human CD10 antibody 
was used as the recognition element on NPs (diameter: 
63 nm ± 4 nm). The mononuclear lymphoid cells were 
incubated with the CD10 NPs and then washed with 
phosphate buffered saline (PBS) to remove unbound 
NPs. Fluorescence microscopy was then used to 
image the leukemia cells.  The brightly fluorescent 
cells bound with NPs were easily detected under 
the fluorescence microscope. Control experiments 
without antibody and specificity studies with non-
target cells showed the effectiveness of this method in 
the selective detection of leukemia cells [31].
Aside from antibody-mediated recognition, 
other affi nity reagents, such as receptor ligands and 
recognition peptides, can also be attached onto NPs 
in order to label cell-membrane proteins. For instance, 
folic acid, a small vitamin molecule recognized by 
cancer cells, was attached to dye-doped silica NPs 
and targeted to SCC-9 cancer cells, which overexpress 
folate receptors [59]. Laser scanning confocal images 
demonstrated that folate-fluorescent NPs were 
internalized via a receptor-mediated endocytosis 
process by the SCC-9 cells in much larger amounts 
compared to the normal human dermal fibroblast 
cells, thus confi rming the effi cacy and robustness of 
the detection system for human squamous cancer 
detection. 
Peptide-targeted uptake is another efficient 
technique for cancer cell imaging. This technique is 
based on the  propensity of the cells to recognize and 
internalize NPs labeled with specific peptides (e.g., 
HIV-derived TAT peptide), and even deliver them to 
specific cellular compartments, such as the nucleus. 
Human lung adenocarcinoma (A549) cells (in vitro) 
and rat brain tissue (in vivo) were successfully labeled 
using TAT-labeled NPs (70 nm in diameter). Using 
this strategy, diagnostic and therapeutic agents can be 
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delivered to the biological target of interest [47].
Recently, aptamers have emerged as a novel class 
of ligands. Aptamers are short strands of DNA/
RNA for recognition of a variety of targets including 
proteins and small molecules as well as complex 
samples. Aptamers have signifi cant advantages over 
antibodies and peptides, including high affinity, 
excellent specificity, and lack of immunogenicity 
[60]. Aptamers can be prepared at lower cost than 
antibodies via automated synthesis, which allows 
directed modifications for further chemistry and 
engineering (e.g., immobilization functionalities) 
onto silica NPs. Specific targeting and visualization 
of acute leukemia cells with aptamer-conjugated 
NPs have been developed using fluorescence 
microscopy or flow cytometry [61, 62]. Compared 
with fluorophore-aptamer conjugates, NP-aptamer 
conjugates greatly increase the fluorescence signal 
from the cell. This property shows the potential 
applications of NPs in the elucidation of cells 
with low densities of aptamer binding sites, or 
with relatively weak binding probes where the 
fluorescence signal from the fluorophore is too weak 
for observation, where as the strong NP signal is easily 
detectable. Therefore, NPs can significantly improve 
our ability to perform cellular imaging and targeting.
3.2   Ultrasensitive single bacterium detection
The rapid and accurate detection of trace amounts of 
organisms, such as pathogenic bacteria, is important 
for food and water safety, clinical diagnosis, and 
the prevention of accidental outbreaks. In the case 
of intentional terrorist acts, early detection of trace 
amounts of pathogenic microorganisms is critical. 
However, current bacteria detection methods rely 
on the ability of microorganisms to grow into visible 
colonies over time in special growth media, which 
may take 1 5 days. Under these conditions, detection 
of trace amounts of bacteria, which typically requires 
amplifi cation or enrichment of the target bacteria in 
the sample, would require an even greater amount 
of time for detection. Thus, time constraints and 
diffi culty of on-site analysis present major obstacles 
to optimal bacteria detection. To overcome these 
limitations, a new type of NP-based bacteria detection 
method has now been developed [35]. Specifically, 
antibodies against E. coli O157:H7 were conjugated 
to dye-doped silica NPs (diameter: 60 nm ± 4 nm). 
By varying the doping ratio of the three tandem 
dyes, fl uorescence resonance energy transfer (FRET)-
mediated emission signatures were tuned, and the 
NPs (diameter: 70 nm ± 5 nm) exhibited different 
colors under single wavelength excitation (488 nm), 
forming NP-antibody conjugates or nanoprobe 
complexes. Under these conditions, the NP-antibody 
conjugates specifi cally associate with E. coli O157:H7 
cells and generate high intensity fl uorescence signals 
in 30 min, but not with E. coli DH5α cells, which 
lack the surface O157:H7 antigens. The dye-doped 
NPs are hundreds of times smaller than bacteria; 
thus, by conjugating the NPs with antibodies that 
specifically recognize the bacterial surface antigens, 
as many as 104 NPs can bind to the surface of each 
bacterial cell. Such high numbers of surface-bound 
NPs should generate suffi cient fl uorescence signal for 
detection, thereby achieving ultrasensitive detection 
of bacterial cells. Furthermore, since this method 
does not require an amplifi cation or enrichment step, 
the bacterial detection process can be adapted to real-
time detection. 
In order to adapt the NP-based assay for 
routine use in bacteria detection, high-throughput 
determination of bacteria samples is critical. To 
determine large numbers of bacteria, the single-
bacterium assay noted above can be easily adapted 
by testing many aliquots of samples simultaneously 
with a plate reader fluorometer [35]. More than 300 
samples can be detected with a single-bacterium 
detection limit. This method is capable of determining 
the existence of a single bacterium with 99.99% 
accuracy when compared to the widely used colony 
forming units/mL count (CFU) on agar plates. The 
results were further confirmed using a laboratory-
made fl ow cytometer which precisely detected single 
bacterial cells with antibody-conjugated NPs bound 
to them and recoded the fluorescence spike when 
the cells flowed through the detection channel [63]. 
The total time for the sample detection and analysis 
with this fl ow system was only a few minutes, which 
minimized the duration of the bacteria assay even 
further.
To test the utility of the method for bacteria 
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detection in real samples, the number of E. coli 
O157:H7 in several spiked ground beef samples 
was determined. The results confi rmed that a single 
bacterium recovered from a ground beef sample 
could be effectively detected, and the effects of 
potential interferences, such as fat in the ground beef, 
were negligible [35].
3.3   DNA and microarray detection
DNA and ol igonucleotide microarrays have 
revolutionized gene expression profi ling by allowing 
highly parallel and quantitative monitoring of gene 
transcripts from an organism [64]. This advance 
has made it possible to tackle qualitatively different 
questions in biology and medicine. Despite the 
extensive profiling and genotyping capability of 
microarrays, one of the diffi culties of this technology 
is accurate detection of low-abundance targets. 
This problem can be solved by either enhancing the 
detection sensitivity or increasing the fluorescence 
signal. 
In order to increase the fluorescence signal of 
the gene target, fluorescent silica NPs have been 
exploited as probes for DNA/microarray detection. 
The first lab-based trial was based on a sandwich 
assay [65]. Capture DNA was immobilized onto a 
glass surface and hybridized with unlabeled target 
DNA complementary to both the capture and probe 
DNA sequences. NPs with attached probe DNA 
were then added. One probe DNA hybridizes one 
target DNA and thus immobilizes one dye-doped 
NP (60 nm in diameter) on the surface, bringing 
tens of thousands of dye molecules for signaling 
(Fig. 3). Using this strategy, the DNA detection limit 
can reach sub-picomolar levels. Single nucleotide 
polymorphism detection is also feasible. Cyanine 
Cy3- and Cy5-doped Au/silica core-shell particles 
have also been prepared and used in two-color 
microarray detection in a sandwich assay format 
[66]. The developed NPs have a core-shell structure 
containing 15 nm Au colloidal cores with 95 dye-
alkanethiol (dT) 20 oligomers chemisorbed on each 
Au particle surface and  silica coatings (10 15 nm) 
bearing thiol functional groups. Use of these dye-
doped NPs resulted in higher sensitivity with a 
detection limit of 1 pmol/L for target DNA. An order 
of magnitude increase in sensitivity enhancement 
and extension of dynamic range was achieved by 
using these NPs as labeling reagents in microarray 
detection compared with fl uorophores.
The NP-based DNA detection strategy can be 
extended to the use of NPs as fluorescent labels for 
DNA and protein microarray technology in order to 
meet the critical demand for enhanced sensitivity [48]. 
Tris(2,2’-bipyridyl)dichlororuthenium(II) hexahydrate 
(RuBpy)-doped silica NPs (60 nm in diameter, each 
containing >10 000 dye molecules) have been used as 
highly sensitive and photostable labels in Affymetrix 
GeneChips technology. As an illustration, biotin-
labeled cRNA samples from a human lung cancer cell 
line were hybridized on the arrays and then incubated 
with streptavidin, followed by washing and staining 
with PEG-biotin-labeled NPs. Even with the present 
unfavorable imaging modality and existing optical 
excitation and detection systems of the GeneChips, 
the fluorescent silica NPs were demonstrated to be 
superior to the traditional streptavidin-phycoerythrin 
(SAPE) staining probe used under similar conditions 
in terms of giving a simplified staining procedure, 
higher photobleaching threshold, and enhanced 
Figure 3   Schematic representation of a sandwich DNA assay based on bioconjugated silica NPs
Capture DNA
Target DNA Probe DNA-NP
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luminescence signal. Having achieved a concentration 
detection limit of 50 fmol/L, the work demonstrated 
the ability of using luminescent NPs as probes for 
commercial microarray systems, making them less 
costly, more reproducible, and potentially quantitative 
than conventional methods. 
3.4   Barcoding tags
The drive to understand biology and medicine at the 
molecular level coupled with the need for accurate 
quantitation demands high-throughput bioanalysis. 
As our understanding of diseases like cancer and 
arteriolosclerosis becomes more detailed, the number 
of identified targets (proteins or oligonucleotides) 
that indicate clinical outcome also increases. A 
typical diagnostic result requires screening for 
numerous particular target molecules in a single 
sample. Multiplexed analysis, whereby numerous 
targets can be detected at the same time, is therefore 
the method of choice for efficiently deciphering 
the amount, relationship or structure of multiple 
analytes simultaneously in a biological sample. 
Simultaneous tracking of a panel of molecular 
markers will allow scientists to understand, classify 
and differentiate complex human diseases. This goal 
is, however, confounded by the use of conventional 
fluorophores (each with a spectral width of 50 200 
nm) since only 4 to 6 different fl uorescent dyes can 
be accommodated without overlapping in the visible 
region of 400 to 800 nm, thereby greatly limiting the 
multiplexing capability.
Recently, however, dye-doped silica NPs have 
been used as novel substrates for multiplexed 
optical encoding [33, 67]. By encapsulating multiple 
fl uorophores simultaneously into the NPs at precisely 
controlled ratios, multiplex analysis becomes 
feasible. For instance, two inorganic dyes, tris(2,2'-
bipyridine)rutheniu(II) chloride hexahydrate (RuBpy) 
and tris(2,2'-bipyridyl)osmium(II) bis(hexafluoro 
phosphate) (OsBpy), were simultaneously doped 
into NPs at precisely controlled ratios using the 
microemulsion process [67]. These two dyes have 
similar structures and share a broad overlapping 
excitation spectrum, but have distinct maximum 
e m i s s i o n  w a v e l e n g t h s  a t  6 1 0  a n d  7 1 0  n m , 
respectively. Therefore, encapsulating the two dyes 
at precisely controlled ratios in NPs yields unique 
barcoding signatures, and a single light source is 
sufficient for reading all the dual-dye-encoded 
NPs (diameter: 70 nm ± 3 nm). Figure 4 displays a 
schematic representation of the dual-fluorophore-
NP encoding system and its multiplexing potential. 
The antibody-conjugated NPs with varying intensity 
ratios were mixed with a cocktail of bacteria. When 
the bacteria NP complex flows through a channel, 
such as a fl ow cytometer, each bacterium-NP complex 
will exhibit the unique fl uorescence signature of the 
attached NPs (Fig. 4). Rapid, sensitive, and selective 
bacteria detection can be achieved in this manner.
Furthermore, in order to generate more versatile 
Figure 4   Schematic representation of the dual dye-encoding system and multiplexing potential. As the bacteria pass through the 
channel, the fl uorescence signals correspond to the different encoded NPs specifi cally attached to the target bacteria
Bacterium 1 antigen
NP 1 antibody
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colors and improve the quantum yield, three 
energy transfer organic fluorophores were also co-
encapsulated inside silica NPs. The three tandem dyes 
were carefully chosen to allow for effi cient fl uorescence 
energy transfer. Fluorescein isothiocyanate (FITC), 
rhodamine 6G (R6G), and 6-carboxyl-X-rhodamine 
(ROX) were employed because of their effective 
spectral overlapping. By varying the doping ratio 
of the three tandem dyes, fluorescence resonance 
energy transfer (FRET)-mediated emission signatures 
were tuned, and the NPs (diameter: 70 nm ± 5 nm) 
exhibited different colors under single wavelength 
excitation (488 nm), which favors multi-color imaging 
applications [33] (Fig. 5(a)). For example, three 
kinds of multi-color FRET NPs were conjugated to 
monoclonal antibodies specific for three pathogenic 
bacteria species (E. coli, Salmonella typhimurium, and 
Staphylococcus aureus). These antibody-NPs were 
incubated with small concentrations of the bacteria. 
After the incubation and washing steps, simultaneous
and sensitive detection of the multiple bacterial 
targets was achieved [68] (Fig. 5(c)). The SEM image 
in Fig. 5(b) confi rms the successful binding between 
the NPs and the Salmonella typhimurium bacteria. 
Additionally, it is noteworthy that the covalent 
triple-dye labeling approach can be further extended 
to any energy transfer dye series allowing the 
generation of a large FRET NP barcoding library. It 
is very probable that such multiplexing technologies 
will allow the advantages of NPs to be combined with 
those of microfluidics and microarrays. In addition, 
non-invasive molecular imaging technologies could 
be developed using these NPs by taking advantage 
of the large Stokes shift of FRET NPs which facilitates 
detection in samples with signifi cant light scattering 
or endogenous fl uorescent compounds. This should 
allow viral particles to be followed in vivo, drug 
molecules to be analyzed in biological systems, and 
tumor cells to be tracked in real time. In order to be 
widely used in these areas, however, more strategies 
need to be established to minimize false positives 
or false negatives during multiplexing, and more 
stringent control of the amount of doped dye is 
required to ensure reproducibility. 
3.5   Separation and purifi cation of biological
        molecules and cells
In recent years, magnetic NPs have been proposed 
for biomedical use [15, 69]. The fact that a magnetic 
fi eld gradient can be used to either remotely position 
or selectively filter biological materials leads to a 
number of separation and purifi cation applications. 
For example, magnetic silica NPs were developed 
for collection of trace amounts of DNA/RNA 
molecules from a complex mixture [43]. The NP-
complex was fabricated with a magnetic NP, a silica 
layer, a biotin avidin linkage, and a molecular 
beacon [70, 71] DNA probe. The magnetic NPs 
serve as magnetic carriers and the molecular beacon 
probes act as recognition elements and indicators 
for specifi c gene sequences. The melting profi les of 
the molecular beacon on the NP surface allow for 
efficient isolation of the target DNA from single 
base mismatched DNA. By varying the temperature 
Figure 5   (a) FRET NP samples with different doping dye concentrations. (b) SEM image of a Salmonella typhimurium (ST) 
bacterium coated with anti-ST-IgG NPs. (c) Confocal image of three bacteria species (E. coli, Salmonella typhimurium, and 
Staphylococcus aureus) specifi cally covered with three types of monoclonal antibody-labeled NPs
（a） （b） （c）
SEI 5.0 kV X19000 1 μm
10.0 μm
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and separating the mixture by magnetization, the 
NP-complex is able to separate trace amounts of 
target DNA/RNA in a complex mixture with high 
specificity and excellent collection efficiency. The 
separation and collection of trace amounts of single 
base mismatched DNA could potentially be an 
effective way to detect mutant cancer genes and 
prevent cancer before it occurs.
In another application, aptamer-labeled magnetic 
silica NPs, along with fluorescent silica NPs, were 
explored for the collection, isolation, and detection 
of intact leukemia cells from mixed cell and whole-
blood samples [61]. Both fluorescent and magnetic 
NPs were modifi ed with an aptamer selective toward 
CCRF-CEM leukemia cells. Magnetic NPs were 
used for selective capture and magnetic collection; 
fl uorescent NPs were used for fl uorescence sensing. 
In as little as 5 min, the leukemia cells were 
magnetically separated and selectively stained. The 
two-particle assay was also able to capture leukemia 
cells from a spiked blood sample. The method has 
been extended to multiple cell collection, where three 
types of cancer cells were selectively collected and 
detected [62]. Figure 6 displays a schematic diagram 
of the multiple cell extraction procedure employed. 
Fetal bovine serum was spiked with three cell types 
for the corresponding cell extraction experiments. 
The cell types were analyzed using the aptamer-
conjugated magnetic NPs and fluorescent NPs. The 
stepwise extraction was performed by adding the 
specifi ed amounts of magnetic NPs for Ramos cells, 
followed by CEM aptamer-conjugated magnetic 
NPs, and finally Toledo-specific magnetic NPs. 
Each set of magnetic NPs was separately incubated 
with the cell samples. The magnetic extractions of 
each step were redispersed in cell media, followed 
by incubation with the CEM aptamer-conjugated 
fluorescent NPs, and the magnetic extraction 
procedure was performed. Similarly, the Toledo and 
Ramos aptamer-conjugated fluorescent NPs were 
subsequently introduced to their respective samples. 
The confocal images (Fig. 6) show the extraction of 
all three cells treated with all the aptamer-conjugated 
NPs. The result demonstrates the wide applicability 
of this methodology for medical diagnostics and cell 
enrichment and separation. 
Figure 6   Schematic representation of the multiple extraction procedure from fetal bovine serum with 
the magnetic NPs being added and extracted stepwise and the corresponding fluorescent NPs (tris(2,2’-
bipyridyl)dichlororuthenium (II) hexahydrate (RuBpy), tetramethylrhodamine (TMR), and cyanine Cy5 NPs) being 
added after magnetic extraction of cell samples. The fl uorescence images display the extracted cell samples 
stained with specifi c aptamer-conjugated fl uorescent NPs
MNP 1 MNP 2 MNP 3




CEM cell Toledo cell Ramos cell
（a） （b） （c）
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3.6   Gene/drug delivery 
I t  i s  only one step from nanotechnology to 
nanomedicine,  which may be defined as the 
monitoring, repair, construction, and control of 
human biological systems at the molecular level, 
using engineered nanodevices and nanostructures. 
A key issue in the practice of this novel science is the 
proper distribution of drugs and other therapeutic 
agents within a patient’s body. Because of their 
ability to control drug release and target particular 
organs/tissue, to act as carriers of oligonucleotides in 
antisense therapy, and to deliver proteins, peptides, 
and drugs, silica NPs have attracted considerable 
attention in the biomedical fi eld. 
For example, fluorescent silica NPs can act as 
nonviral vectors for gene delivery and biophotonics 
methods  may be  used to  opt ica l ly  monitor 
intracellular trafficking and gene transfection. The 
potential of cationic silica NPs (pure silica NPs 
without surface modifi cations do not seem to be able 
to condense and deliver DNA) was investigated for in 
vivo gene transfer [72]. The NPs were tested for their 
ability to transfer genes in vivo in the mouse lung, 
and a two-fold increase in the expression levels was 
found with silica particles in comparison to enhanced 
green fl uorescent protein (EGFP) alone. Very low or 
no cell toxicity was observed, suggesting that silica 
NPs have genuine potential as candidates for gene 
transfection. Another example involves organically 
modifi ed mesoporous silica NPs which were used for 
in vivo gene delivery to the brain. It has been shown 
that these amino group-functionalized NPs not only 
bind and protect plasmid DNA from enzymatic 
digestion but also transfect cultured cells and 
deliver DNA to the nucleus [73]. Moreover, the gene 
delivery process does not cause the tissue damage or 
immunological side effects that have been commonly 
observed with viral-mediated gene delivery [74, 75].
Silica NPs are also promising candidates for 
improved drug delivery systems because of their 
intrinsic hydrophilicity, biocompatibility, and 
nontoxicity, as well as the excellent protection they 
provide for their encapsulated drugs. With drug 
molecules loaded into silica NPs, surface modifi cation 
of the NPs with biorecognition entities can allow 
specific cells or receptors in the body to be located. 
Upon target recognition, NPs can then release 
their drug payload at a rate precisely controlled 
by tailoring the internal structure of the particles 
according to a desired diffusion (release) profi le [23]. 
Furthermore, after the NPs are effi ciently taken up by 
tumor cells, irradiation of the photosensitizing drug 
entrapped in the NPs results in efficient generation 
of singlet oxygen, which, in turn, causes significant 
cancer cell damage [73]. 
Interestingly, the discovery that mammalian 
cells take up and internalize mesoporous silica NPs 
without cytotoxic effects opened the door to the 
use of these materials as a drug delivery system 
[76]. The high surface area (>900 m2/g), tunable 
pore diameter (2 20 nm) and uniform mesoporous 
structure (hexagonal channels or cubic pores) of the 
mesoporous silica NPs offer unique advantages for 
loading and releasing large quantities of biomedical 
agents. Mesopores loaded with guest molecules were 
capped by inorganic NPs, or large organic molecules, 
via a chemically cleavable disulfide linkage to the 
mesoporous NP surface. Since drug molecules are 
effectively physically trapped, they are unable to 
leach out of the mesoporous NP host (average particle 
size of 200.0 nm and an average pore diameter of 
2.3 nm), thus preventing any premature release. 
In this case, the release was finally triggered by 
exposing the capped mesoporous NPs to chemical 
stimulation that could cleave the disulfide linker, 
thereby removing the NP caps and releasing the pore-
entrapped drug molecules. Compared with many 
current biodegradable polymer-based drug delivery 
systems that rely on the hydrolysis-induced erosion 
of the carrier structure, the mesoporous NP structure 
provides the ability to release the cargo in a controlled 
manner [77]. However, thiol oxidation may lead to 
cell death, which is a concern for in vivo applications.
Magnetic silica NPs for gene delivery and drug 
targeting have also been effectively demonstrated in 
animal models. Once the magnetic NPs have been 
taken up by a tumor, an alternating magnetic field 
is applied that couples to the particles, resulting 
in efficient local heating [78]. Apoptosis may be 
induced, and cells are destroyed thus increasing the 
effi cacy of either chemotherapy or radiotherapy. 
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3.7   Multifunctional silica NPs
In clinical trials today, it is common to use one set 
of agents for diagnosis and another set of agents for 
therapeutics and treatment. We should ask whether 
it is possible to combine these two procedures into 
a single modality that would improve our ability 
to achieve diagnosis and treatment, and even 
monitoring in real time. It is this integration of 
nanochemistry, targeting systems, and biotechnology 
that has permitted the fabrication of multifunctional 
NP probes for bioimaging, diagnostic, and therapeutic 
purposes. Multifunctional NPs in general have 
at least a tripartite constitution, featuring a core 
constituent material, a therapeutic and/or imaging 
payload, and biological surface modifiers, which 
enhance the biodistribution and tumor targeting of 
the NP dispersion (Fig. 7). Recently, multifunctional 
magnetic and fl uorescent NPs have been developed 
that consist of a thin silica shell encapsulating 
magnetic NPs as well as fluorescent dyes [24, 79, 
80]. These NPs (100 nm ± 10 nm in diameter) are 
potentially useful in a variety of areas because 
they can be simultaneously manipulated with an 
external magnetic field and characterized in situ by 
optical spectroscopy. For example, multifunctional 
f luorescent,  radio-opaque and paramagnetic 
silica NPs have been synthesized for multifaceted 
bioimaging applications [81]. In addition, near-
infrared (NIR) fl uorescent and magnetic NPs (32 nm 
in diameter) have been successfully applied in dual 
labeling of brain tumors which could help surgeons 
during the preoperative planning phase and during 
surgical resection of tumors [82].  Moreover, when the 
NP surface was functionalized with a biotargeting 
group, such as leutinizing hormone-releasing 
hormone, the NPs targeted receptor-specific cancer 
cells [83]. Subsequent exposure to a DC magnetic 
fi eld resulted in the selective destruction of the cancer 
cells. This study showed that multifunctional NPs are 
potential diagnostic and therapeutic tools for cancer 
and infectious diseases. Using multifunctional NPs, it 
is possible to combine the ability to capture, separate, 
visualize, and treat cells (or proteins) within one 
reagent. 
4. Challenges and trends
Although researchers have made advances using 
silica NPs in bioimaging, labeling, separation, 
disease diagnosis, and therapy, several obstacles 
and limitations still exist. First, dye leakage from 
the fl uorescent silica NPs over time needs thorough 
investigation. This phenomenon decreases particle 
brightness, increases background signal, and 
exposes the dyes to their environment. Second, 
nonspecific binding of silica NPs has not yet been 
resolved. Control strategies need to be established 
for improving NP dispersion in solution to prevent 
agglomeration, decrease background noise, and 
reduce nonspecifi c adhesion to surfaces. In addition, 
for ultrasensitive analysis to be achieved, an optimal 
number of dye molecules need to be doped inside 
one NP. However, there is always a compromise 
between NP size and the brightness. Large and bulky 
sized NPs may block some biological binding sites 











Figure 7   Multifunctional NPs with the ability to carry one or more 
therapeutic agents: biomolecular targeting through one or more 
conjugated antibodies or other recognition agents; imaging signal 
amplification, by way of doping fluorophores or other contrast 
agents; and biobarrier avoidance, exemplifi ed by polyethylene glycol 
(PEG) to avoid macrophage uptake
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applications, such as the FRET-based investigations. 
It has been suggested that NP-mediated cellular 
response is size-dependent and that 40 to 50 nm NPs 
form the critical cutoff point for receptor-mediated 
internalization [84]. Therefore, the balance between 
size and intensity must be optimized for different 
applications.   
Silica NPs have found broad and successful 
applications in a variety of in vitro bioassays. They 
have also found practical implementation in the 
biomedical field for diagnosis with proper and 
efficient delivery of pharmaceuticals. However, 
applications of these tools in medical research and 
clinical practice require further development. This 
is illustrated by the cytotoxicity of silica NPs, which 
must be fully investigated before considering the 
intravenous injection of silica NPs into diseased 
tissues and organs in the human body. For drug 
delivery, there are barriers to controlling the 
interaction of NPs within the body before this 
technology can be effectively translated into practical 
therapeutic regimens. Methods of targeting NPs to 
specifi c sites of the body while avoiding capture by 
organs, such as the liver and spleen, must also be 
addressed. Currently, however, few data on silica 
NP toxicity exist. On the one hand, colloidal silica 
was shown to induce red blood cells hemolysis [85] 
and blood monocytes injury [86]. On the other hand, 
surface-modified silica NPs have been successfully 
used for in vivo gene therapy [87] and labeling of 
human mesenchymal stem cells [80]. Furthermore, 
little is known about the possible in vivo degradation 
processes of these particles and the toxicity of the 
resulting products which limits their biomedical 
applications.
Although significant challenges remain in 
pushing this field into clinically viable therapies, 
there is a good reason for optimism and it is feasible 
that nanopharmaceuticals might become a reality 
in the future. By integrating nanotechnology into 
complex biological systems, we may achieve the 
detection and prevention of disease at the earliest 
stages of development. In addition, we can also 
envisage complex bio-NPs that incorporate biological 
functions being fully integrated into nanodevices for 
light/energy harvesting, biosensing or molecular 
electronics, opening the possibility of fabrication of 
truly smart bioprobes and biosensors. Overall, we 
have far from exhausted the biological potential of 
bioconjugated silica NPs. Thus, the current picture 
of silica NP technology is bound to evolve rapidly in 
medical diagnostics, targeted therapeutics, molecular 
biology, and cell biology, resulting in scientific 
and commercial opportunities that are virtually 
unimaginable at this time.
5. Concluding remarks
The demand for highly sensitive nonisotopic 
bioanalysis systems for biotechnology applications, 
such as those needed in clinical diagnostics, food 
quality control, and drug delivery, has driven 
research in the use of nanomaterials for biomedical 
and biotechnological applications. As one such 
nanomaterial,  bioconjugated silica NPs have 
demonstrated unique advantages by virtue of their size 
and their novel optical, magnetic, and other properties. 
As robust and bright light emitters, dye-doped 
silica NPs have been adopted as a new class of 
fl uorescent labels. Six years after the fi rst experiments 
on their uses in biological applications, there have 
been dramatic improvements in understanding 
surface chemistry, biocompatibility, multiplexing 
capability, and targeting specificity. Magnetic 
silica NPs have also been applied in biomolecule/
cel l  sort ing and immunoassay in pathology 
laboratories. As soon as these NPs can be successfully 
incorporated into a complex biological system, they 
will have far-reaching impact in molecular biology, 
biotechnology, and nanomedicine.
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